Conditions: Soft Tissue Sarcoma; Bone Tumors; Small Round-cell Sarcomas
Intervention: Drug: Trabectedin
Sponsor: Grupo Espanol de Investigacion en Sarcomas
Recruiting
Feeds
5250 items (5250 unread) in 74 feeds
Acinar Cell Carcinoma
(12 unread)
Acinic Cell Carcinoma
(18 unread)
Adenoid Cystic Carcinoma
(90 unread)
Adrenal Gland Cancer
(452 unread)
Ampulla Of Vater
(60 unread)
Anal Cancer
(494 unread)
Angiosarcoma
(130 unread)
Appendix Cancer
(85 unread)
Bile Duct Cancer
(664 unread)
Brain and CNS
(597 unread)
Carcinoid
(153 unread)
Endocrine/Neuroendocrine
(652 unread)
Gall Bladder Cancer
(338 unread)
Hemangioendothelioma
(117 unread)
Hepatoblastoma
(151 unread)
Pancreas
(60 unread)
Phyllodes
(26 unread)
PMP and Mucinous Tumors
(39 unread)
Rhabdomyosarcoma
(187 unread)
Sarcoma
(925 unread)
Trial - Rhabdomyosarcoma (6 unread)
-
Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
Posted: November 23rd, 2021, 3:00pm GMT
-
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Posted: November 11th, 2021, 3:00pm GMT
Conditions: Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Leiomyosarcoma; Liposarcoma; Angiosarcoma; Synovial Sarcoma; Rhabdomyosarcoma; Spindle Cell Sarcoma; High Grade Sarcoma; Bone Sarcoma; Osteosarcoma; Ewing Sarcoma of Bone
Interventions: Drug: Gemcitabine; Drug: 9-ING-41; Drug: Docetaxel
Sponsors: Brown University; Actuate Therapeutics
Not yet recruiting -
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Hepatocellular Carcinoma
Posted: November 2nd, 2021, 2:00pm GMT
Conditions: Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor, Somatic; Liposarcoma; Wilms Tumor; Yolk Sac Tumor
Interventions: Genetic: CATCH T cells; Drug: Cytoxan; Drug: Fludara
Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine; Houston Methodist Hospital, TX
Not yet recruiting -
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
Posted: October 26th, 2021, 2:00pm GMT
Conditions: Solid Tumor; Lymphoma; Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Non-rhabdomyosarcoma Soft Tissue Sarcoma
Intervention: Drug: Surufatinib in combination with Gemcitabine
Sponsor: Hutchison Medipharma Limited
Not yet recruiting -
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Posted: January 20th, 2021, 3:00pm GMT
Conditions: Liver Cancer; Rhabdomyosarcoma; Malignant Rhabdoid Tumor; Liposarcoma; Wilms Tumor; Yolk Sac Tumor
Interventions: Genetic: CARE T cells; Drug: Cytoxan; Drug: Fludara
Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine
Not yet recruiting -
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Posted: December 22nd, 2015, 3:00pm GMT
Condition: Solid Tumors Harboring NTRK Fusion
Intervention: Drug: Larotrectinib (Vitrakvi, BAY2757556)
Sponsor: Bayer
Recruiting